How is the Lucid Diagnostics Inc today?

The Lucid Diagnostics Inc today is trading in the green, up by 7.56% at 1.28.

How has Lucid Diagnostics Inc performed historically?

The Lucid Diagnostics Inc is currently trading up 7.56% on an intraday basis in the past week the index rose 7.56%. The index has been down -12.33% in the past quarter and rose 37.63% in the past year. You can view this in the overview section.

What is Lucid Diagnostics Inc Annual Revenue?

Lucid Diagnostics Inc Annual Revenue rose 79%, in the last year to $4.35 M. Its sector's average revenue growth for the last fiscal year was 9.8%.

What is Lucid Diagnostics Inc Annual Net Profit?

Lucid Diagnostics Inc Annual Net Profit rose 13.55% in the last year to $45.53 M. Its sector's average net profit growth for the last fiscal year was 6.77%.

What is Lucid Diagnostics Inc Price to Earning Ratio?

Lucid Diagnostics Inc Price to Earning Ratio is -2.96, which is negative.

What is Lucid Diagnostics Inc Stock Price?

Lucid Diagnostics Inc Stock Price rose 37.63% and outperformed its sector by 28.33% in the past year.

What is Lucid Diagnostics Inc Quarterly Revenue?

Lucid Diagnostics Inc Quarterly Revenue rose 15.1% YoY to $1.2 M. Its sector's average revenue growth YoY for the quarter was 8.16%.

What is Lucid Diagnostics Inc Quarterly Net profit?

Lucid Diagnostics Inc Quarterly Net profit fell 6.57% YoY to $11.54 M. Its sector's average net profit growth YoY for the quarter was 39.22%.

What is Lucid Diagnostics Inc Mutual Fund Holding?

Lucid Diagnostics Inc Mutual Fund Holding increased by 0.03% in the last quarter to 1.32.

What is Lucid Diagnostics Inc Interest Coverage Ratio?

Lucid Diagnostics Inc Interest Coverage Ratio is -1750.12, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Lucid Diagnostics Inc Institutional Holding?

Lucid Diagnostics Inc Institutional Holding decreased by 0.05% in the last quarter to 3.3.

Lucid Diagnostics Inc XNAS: LUCD

Lucid Diagnostics Inc Live Share Price Today, Share Analysis and Chart

Name: Lucid Diagnostics Inc: Is Infosys Ltd. worth buying?
Item: Lucid Diagnostics Inc
Rating: 1.50941675
Author: Trendlyne DVM scores

about

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of dev...

1.28 0.09 (7.56%)

28.89% Fall from 52W High

1.5M XNAS Volume

XNAS 14 May, 2025 5:30 PM (EDT)

Board Meeting

The latest board meeting for Lucid Diagnostics Inc took place on 14 May 2025, for the purpose of Lucid Diagnostics Inc First Quarter Earnings Conference Call for 2025 See details

Not Eligible

Expensive Valuation

1.2 / 100

Technically Neutral

59.2 / 100

1Yr Price target upside is 193%

6 analysts

Lucid Diagnostics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lucid Diagnostics Inc Live Share Price Today, Share Analysis and Chart

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of dev...

28.89% Fall from 52W High

SWOT Analysis

Lucid Diagnostics Inc Live Price Chart

Lucid Diagnostics Inc FAQ

How is Lucid Diagnostics Inc today?

Lucid Diagnostics Inc today is trading in the green, and is up by 7.56% at 1.28.

How has Lucid Diagnostics Inc performed historically?

Lucid Diagnostics Inc is currently trading up 7.56% on an intraday basis. In the past week the stock rose 7.56%. stock has been down -12.33% in the past quarter and rose 37.63% in the past year. You can view this in the overview section.